Dalotuzumab

Dalotuzumab
Dalotuzumab ?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target IGF-1 receptor
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 1005389-60-5 N
ATC code None
UNII 6YI1L648RH YesY
Chemical data
Formula C6528H10086N1730O2018S40 
Mol. mass 146.4 kDa
 N(what is this?)  (verify)

Dalotuzumab is a humanized monoclonal antibody designed for the treatment of cancers.[1]

Dalotuzumab was developed by Merck & Co., Inc.

References

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Dalotuzumab". American Medical Association. http://www.ama-assn.org/resources/doc/usan/dalotuzumab.pdf.